✦ LIBER ✦

A randomized prospective study of vindesine versus doxorubicin and cyclophosphamide in the treatment of epidermoid lung cancer

✍ Scribed by Dan W. Luedke; Susan L. Luedke; Paul Petruska; G. O. Broun; John Leavitt; And Jean Schlueter

Publisher: John Wiley and Sons
Year: 1983
Tongue: English
Weight: 463 KB
Volume: 51
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19830301)51:5<778::aid-cncr2820510505>3.0.co;2-o

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A prospective randomized trial of doxoru

A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer

✍ Massimo Lopez; Alma Contegiacomo; Patrizia Vici; Concetta Dello Ioio; Luigi Di L 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 2 views

Seventy-six patients with advanced breast cancer were entered into the current study. They were randomized to receive either idarubicin (IDA) 45 mg/m2 orally or doxorubicin (DX) 75 mg/m2 intravenously (IV), both drugs being administered every 3 weeks. Among 37 evaluable patients who received DX trea

Phase III trial of cyclophosphamide vers

Phase III trial of cyclophosphamide versus cyclophosphamide, doxorubicin, and methotrexate in hormone-refractory prostatic cancer: A hoosier oncology group study

✍ Scott Saxman; Rafat Ansari; Ray Drasga; Michael Miller; Ben Wheeler; John McClea 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 489 KB 👁 1 views

VP-16 plus cyclophosphamide in the treat

VP-16 plus cyclophosphamide in the treatment of advanced lung cancer

✍ J. Estape; A. Milla; A. Agusti; J. Sanchez-Lloret; P. Santabarbara; C. Rozman 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB 👁 1 views

The addition of cisplatin to cyclophosph

The addition of cisplatin to cyclophosphamide-doxorubicin-etoposide combination chemotherapy in the treatment of patients with small cell lung carcinoma : A randomized study of 457 patients

✍ Thierry Urban; Claude Chastang; François-Xavier Lebas; Jean-Paul Duhamel; Guy Ad 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

## BACKGROUND. To assess whether the addition of cisplatin (100 mg/m 2 administered intravenously on Day 1) to CDE (cyclophosphamide [1000 mg/m 2 on Day 1], doxorubicin [45 mg/m 2 on Day 1], and etoposide [150 mg/m 2 on Days 1 and 2] combination is useful in the treatment of patients with small cel

A prospective, randomized phase III tria

A prospective, randomized phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma

✍ Cesar Blajman; L. Balbiani; J. Block; F. Coppola; R. Chacon; L. Fein; S. Bonicat 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

## Background: A prospective, multicenter, randomized, phase iii trial comparing the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide (fac) with a combination of vinorelbine and doxorubicin (na) in the treatment of patients with advanced breast carcinoma w

Randomized study comparing 4′-epi-doxoru

Randomized study comparing 4′-epi-doxorubicin (Epirubicin) versus doxorubicin as a part of induction treatment in adult acute lymphoblastic leukemia

✍ Manisha Bhutani; Lalit Kumar; Amish Vora; Narendra Bhardwaj; Ashutosh Kumar Path 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views